Intravenous iron administration: new observations and time for the next steps | Zendy

Günter Weiß | Zendy; Florian Kronenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intravenous iron administration: new observations and time for the next steps

Author(s) -

Günter Weiß,

Florian Kronenberg

Publication year - 2014

Publication title -

kidney international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.499

H-Index - 276

eISSN - 1523-1755

pISSN - 0085-2538

DOI - 10.1038/ki.2014.324

Subject(s) - intravenous iron , medicine , dialysis , hemodialysis , randomized controlled trial , intensive care medicine , iron deficiency , anemia

In this issue of Kidney International, the Dialysis Outcomes and Practice Patterns Study reports that hemodialysis patients with monthly intravenous iron supplementation of 300-399 mg or ⩾400 mg had a 13 or 18% higher risk of dying, respectively, compared with those receiving 100-199 mg per month, with no obvious differences in cause-specific mortalities. This study supports that randomized controlled trials are urgently needed to identify optimized iron supplementation strategies for anemic dialysis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research